Opiant Pharmaceuticals, Inc.
(NASDAQ : OPNT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
2.49%200.461.2%$531.90m
GILDGilead Sciences, Inc.
3.33%75.200.9%$475.06m
BIIBBiogen Inc.
1.63%333.781.3%$390.95m
CELGCelgene Corporation
1.97%83.441.2%$345.85m
ILMNIllumina, Inc.
1.88%319.313.5%$303.25m
REGNRegeneron Pharmaceuticals, Inc.
4.48%394.452.6%$238.71m
ALXNAlexion Pharmaceuticals, Inc.
4.77%127.292.0%$225.35m
VRTXVertex Pharmaceuticals Incorporated
3.10%183.161.9%$217.01m
SRPTSarepta Therapeutics, Inc.
5.12%138.0616.4%$179.87m
AAgilent Technologies, Inc.
2.13%67.031.5%$160.84m
BMRNBioMarin Pharmaceutical Inc.
4.22%103.654.4%$141.09m
LGNDLigand Pharmaceuticals Incorporated
6.04%212.1623.3%$122.33m
VKTXViking Therapeutics, Inc.
7.61%15.280.9%$120.55m
NKTRNektar Therapeutics
3.20%50.655.6%$112.54m
EXASExact Sciences Corporation
1.28%66.6125.3%$104.33m

Company Profile

Opiant Pharmaceuticals, Inc. is a biopharmaceutical company, which develops pharmaceutical solutions for common addictions and related disorders. The company focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.